Initiatives taken by government to increase the investment in orphan drugs development driving
the growth of orphan drugs market.
Key players operating the orphan drugs market are Acorda Therapeutics, Actelion
Pharmaceuticals Ltd., Amgen, Alexion Pharmaceuticals, Baxter international, Bayer healthcare
pharmaceuticals, Biomarin Pharmaceuticals, Novartis, F.Hoffmann-La Roche AG, Johnson and
Johnson and many others. The increase in investments, and some initiatives taken by
government helping the orphan drug manufacturers. For instance, U.S. government provides
50% of tax credit on the research and development expenses spent on the orphan drugs
development by manufacturers. However the high cost of the orphan drugs and generation of
small sales from it is amongst those factors which is lowering the interest of companies for
market.
Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/500
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com